Your browser doesn't support javascript.
loading
Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry.
Kojanova, Martina; Hugo, Jan; Velackova, Barbora; Cetkovska, Petra; Fialova, Jorga; Dolezal, Tomas; Tichy, Martin; Gkalpakiotis, Spyridon.
Affiliation
  • Kojanova M; Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
  • Hugo J; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
  • Velackova B; Value Outcomes, Prague, Czech Republic.
  • Cetkovska P; Department of Dermatovenereology, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic.
  • Fialova J; Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
  • Dolezal T; Value Outcomes, Prague, Czech Republic.
  • Tichy M; Department of Dermatology and Venereology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Olomouc, Czech Republic.
  • Gkalpakiotis S; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
J Dermatolog Treat ; 33(6): 2827-2837, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35635185

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Interleukin-17 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Dermatolog Treat Journal subject: DERMATOLOGIA Year: 2022 Document type: Article Affiliation country: República Checa

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Interleukin-17 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Dermatolog Treat Journal subject: DERMATOLOGIA Year: 2022 Document type: Article Affiliation country: República Checa